Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.346, Iss.1, 1998-04, pp. : 1-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine

By Zemek Filip Drtinova Lucie Nepovimova Eugenie Sepsova Vendula Korabecny Jan Klimes Jiri Kuca Kamil

Expert Opinion on Drug Safety, Vol. 13, Iss. 6, 2014-06 ,pp. : 759-774

Informa Healthcare

Access to resources Recommend Favorite

Acetylcholinesterase Inhibitors and Sleep Architecture in Patients with Alzheimer's Disease

By Cooke Jana R. Loredo Jose S. Liu Lianqi Marler Matthew Corey-Bloom Jody Fiorentino Lavinia Harrison Tamara Ancoli-Israel Sonia

Drugs & Aging, Vol. 23, Iss. 6, 2006-01 ,pp. : 503-511

Adis International

Access to resources Recommend Favorite

Progress in acetylcholinesterase inhibitors for Alzheimer's disease: an update

By Tumiatti Vincenzo Bolognesi Maria Laura Minarini Anna Rosini Michela Milelli Andrea Matera Riccardo Melchiorre Carlo

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 4, 2008-04 ,pp. : 387-401

Informa Healthcare

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease

By Gauthier S.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1511-1520

Informa Healthcare

Access to resources Recommend Favorite

Duration of Therapy with Acetylcholinesterase Inhibitors in Patients with Mild-to-Moderate Alzheimer's Disease as Reported in the Literature

By Melik Razan El Dubil Amanda Pound Melanie W.

The Consultant Pharmacist, Vol. 29, Iss. 6, 2014-06 ,pp. : 400-407

American Society of Consultant Pharmacists

Access to resources Recommend Favorite